Titre:
  • Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial
Auteur:Gelber, Richard; Wang, Xin Victoria; Cole, Bernard B.F.; Cameron, David A; Cardoso, Fatima; Tjan-Heijnen, Vivianne C G; Krop, Ian; Loi, Sherene; Salgado, Roberto; Kiermaier, Astrid; Frank, Elizabeth E.S.; Fumagalli, Debora; Caballero, Carmela; Azambuja, Evandro; Procter, Marion; Clark, Emma; Restuccia, Eleonora; Heeson, Sarah; Bines, Jose; Loibl, Sibylle; Piccart-Gebhart, Martine
Informations sur la publication:European journal of cancer, 166, page (219-228)
Statut de publication:Publié, 2022-05
Sujet CREF:Cancérologie
Mots-clés:Adjuvant therapy
HER2-positive early breast cancer
Pertuzumab
STEPP (Subpopulation Treatment Effect Pattern Plot)
TILs (tumour infiltrating lymphocytes)
Trastuzumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2022.01.031
info:pii/S0959804922000648
info:scp/85126564916